🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Harkaa (Hepatocellular Carcinoma) › Illinois › Chicago

Qorannoo klinikaalii Dhibee Harkaa (Hepatocellular Carcinoma) Chicago, IL keessatti

Qorannoo 16 Dhibee Harkaa (Hepatocellular Carcinoma) f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Exelixis Clinical Site #26, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05176483

National Liver Cancer Screening Trial

Namoota walitti qabaa jiraSadarkaa 4
  • Northwestern University, Chicago
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06084234

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Local Institution - 0107, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07291076

Defining the Ablative Dose for Y-90 TARE

Namoota walitti qabaa jiraSadarkaa 2
  • Northwestern University, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07586046

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • RUSH University Medical Center, Chicago
  • University of Chicago, Chicago
Umuriin 22 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06486454

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06921785

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Lurie Children's Hospital-Chicago, Chicago
12 Months – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04851119

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

Namoota walitti qabaa jiraSadarkaa 3
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07166406

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • University of Chicago Comprehensive Cancer Center, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05168163

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Northwestern University, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT07042919

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Namoota walitti qabaa jiraSadarkaa 1
  • Clinical Trial Site, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT06600321

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

Namoota walitti qabaa jiraSadarkaa 2
  • Northwestern University, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Cam-2026 · NCT05620771

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Namoota walitti qabaa jiraSadarkaa 4
  • University of Chicago Medical Center, Chicago
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 22-Ama-2026 · NCT04373564

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Chicago
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

The Dragon PLC Trial (DRAGON-PLC)

Namoota walitti qabaa jira
  • Rush University Medical Center, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Cam-2025 · NCT06914648

Qorannoo Dhibee Harkaa (Hepatocellular Carcinoma) magaalota biroo keessatti

Qorannoo biroo Chicago keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.